Today: 21 May 2026
Alibaba stock slides as China probes food-delivery price war; BABA investors eye Feb. 19 earnings
10 January 2026
2 mins read

Alibaba stock slides as China probes food-delivery price war; BABA investors eye Feb. 19 earnings

New York, Jan 10, 2026, 11:40 EST — The market has closed.

  • Alibaba’s U.S.-listed shares dropped 2.3% on Friday, erasing some of Thursday’s gains
  • China announced plans to probe competition among food-delivery platforms, including Alibaba
  • Traders are eyeing China’s regulatory moves, updates on AI chip supplies, and Alibaba’s upcoming earnings report due Feb. 19

Alibaba Group Holding Ltd’s shares on the U.S. market slipped 2.3% to $150.96 on Friday, pulling back following a 5.7% jump the previous day.

The dip followed China’s announcement of a probe into aggressive competition among food-delivery platforms run by tech giants like Meituan and Alibaba. The move targets subsidy-fueled price wars. The market regulator flagged “involution-style” competition — a Chinese phrase for cutthroat rivalry that slashes profits — highlighting “instant retail” delivery within an hour as a main battleground. Reuters

Why it matters now: Alibaba is pushing harder on faster delivery and local services to hold its ground as consumer growth slows. Cutting back on subsidies and discounts might dent volumes, but it also tightens the marketing strategies that have kept both merchants and shoppers engaged on its platforms.

Alibaba shares are also reacting to developments in AI hardware. According to Reuters, Nvidia is now demanding full upfront payment from Chinese customers for its H200 AI chips, amid uncertainty over Beijing’s regulatory approval. Some tech companies have been told to hold off on orders as authorities consider domestic chip policies. Nvidia CEO Jensen Huang described demand as “quite high” and said the firm has “fired up our supply chain” to boost output.

Morgan Stanley’s Gary Yu lowered his Alibaba price target to $180 from $200 on Thursday but kept an Overweight rating. He noted that “core e-comm businesses have started to worsen, due to weak consumption.” Yu highlighted that cloud momentum still backs Alibaba’s standing as “China’s Best AI Enabler,” though he warned that rising AI-related expenses could weigh on adjusted EBITA — operating profit before interest, tax, and amortisation. Investing.com

Alibaba’s AI ties keep it in the mix as deal rumors swirl. MiniMax, a hot “AI tiger” startup from China, surged more than 100% in its Hong Kong debut Friday. Reuters reported Alibaba counted among its cornerstone investors. Omdia analyst Lian Jye Su noted the startup’s consumer angle “appealed more” to investors chasing high-growth opportunities. Reuters

Alibaba’s shares fell Friday, pushing weekly volume sharply higher but keeping the stock well under its October highs. The moves appear driven as much by headlines as by company fundamentals. MarketWatch reported that Friday’s trading volume hit roughly 11.4 million shares.

The broader market showed strength Friday as U.S. stocks hit new highs despite a mixed jobs report. The Nasdaq climbed 0.8%, while the S&P 500 gained 0.6%, the Associated Press reported.

Alibaba’s main risk lies squarely in China. Should the investigation lead to stricter subsidy caps or tougher compliance rules, the company might face a tough choice: either curb its delivery expansion or accept weaker margins in the near term. On top of that, any hold-up in importing advanced AI chips could throw a wrench into the cloud growth narrative favored by bulls.

Risk appetite faces its next big test with U.S. consumer inflation data due Tuesday, Jan. 13. The Labor Department will drop the CPI report for December 2025 at 8:30 a.m. ET.

Alibaba’s next major event is its earnings report. Nasdaq currently has the date set for Feb. 19, but that could shift if the company updates its schedule. Investors want to hear about trends in China’s consumer demand, how aggressive delivery subsidies remain, and progress in AI and cloud investments.

Stock Market Today

  • Asian Shares Surge as Oil Prices Dip and Nvidia Drives AI Rally
    May 20, 2026, 10:35 PM EDT. Asian shares surged Thursday following a drop in oil prices and easing pressure from the bond market. South Korea's Kospi led gains with a 6.7% jump, boosted by technology stocks including Samsung Electronics and SK Hynix. Taiwan's Taiex and Japan's Nikkei also climbed. Nvidia's strong quarterly results, showing a 200% profit increase and 85% revenue rise driven by AI chip demand, fueled optimism despite a post-earnings dip. U.S. stocks rallied, with the S&P 500 up 1.1%, helped by a fall in the 10-year Treasury yield to 4.57%. Brent crude fell but managed a slight recovery to $105.50 per barrel amid volatile Iran-related supply concerns. The softening yields eased fears of aggressive rate hikes, supporting equities and growth in AI sector investments.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy
Previous Story

Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut
Next Story

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut

Go toTop